Endpoints News 生物医药· Ayisha Sharma·· 10 天前精选AI 评分65
拜耳获FDA批准用于预防中风的药物Sunharbo
Bayer wins FDA approval for stroke prevention drug Sunharbo
AI 导读
拜耳的asunexian获得FDA批准,用于降低近期发生轻至中度非心源性缺血性中风或高风险短暂性脑缺血发作患者的中风风险。
推荐理由
原文明确给出批准事项,读者可据此判断同类产品的审批进展。
正文 · 原文
Bayer’s asundexian won FDA approval to reduce the risk of stroke in people who recently had a mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news